Cadrenal Therapeutics, Inc.盘中异动股价大涨5.37%

市场透视2025-05-15

北京时间2025年05月15日23时41分，Cadrenal Therapeutics, Inc.（CVKD.us）股票出现异动，股价大幅拉升5.37%。截至发稿，该股报14.90美元/股，成交量1.3226万股，换手率0.67%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.85百万美元，每股收益-2.09美元，毛利-5517.00美元，市盈率-1.59倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535535878?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 23:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535535878","market":"us","top_or_hot":-1,"title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.37%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月15日23时41分，Cadrenal Therapeutics, Inc.（CVKD.us）股票出现异动，股价大幅拉升5.37%。截至发稿，该股报14.90美元/股，成交量1.3226万股，换手率0.67%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.85百万美元，每股收益-2.09美元，毛利-5517.00美元，市盈率-1.59倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234118975ad7cb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.37%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCadrenal Therapeutics, Inc.盘中异动 股价大涨5.37%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 23:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234118975ad7cb&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月15日23时41分，Cadrenal Therapeutics, Inc.（CVKD.us）股票出现异动，股价大幅拉升5.37%。截至发稿，该股报14.90美元/股，成交量1.3226万股，换手率0.67%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.85百万美元，每股收益-2.09美元，毛利-5517.00美元，市盈率-1.59倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234118975ad7cb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234118975ad7cb&s=b","article_id":"2535535878","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234118975ad7cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535535878","pubTimestamp":1747323678,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月15日23时41分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅拉升5.37%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Nucana Plc、Renovaro Inc.、Cabaletta Bio, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为11700.68%、4133.08%、300.20%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为76.92%、63.87%、46.13%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","CVKD":"Cadrenal Therapeutics, Inc.","BK4139":"生物科技","BK4007":"制药","LENZ":"Therapeutics"},"translate_title":"Cadrenal Therapeutics, Inc. stock jumps 5.37% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVKD":1,"LENZ":1},"content_text":"北京时间2025年05月15日23时41分，Cadrenal Therapeutics, Inc.（CVKD.us）股票出现异动，股价大幅拉升5.37%。截至发稿，该股报14.90美元/股，成交量1.3226万股，换手率0.67%，振幅7.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.85百万美元，每股收益-2.09美元，毛利-5517.00美元，市盈率-1.59倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Nucana Plc、Renovaro Inc.、Cabaletta Bio, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为11700.68%、4133.08%、300.20%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Nucana Plc、Briacell Therapeutics Corp C/Wts 26/02/2026(To Pur Com)，振幅分别为76.92%、63.87%、46.13%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。Tecarfarin是一种后期新型口服可逆抗凝剂（血液稀释剂），旨在预防需要长期抗凝治疗的罕见心血管疾病患者因血栓导致的心脏病突发、中风和死亡。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535535878","isCrawlerRequest":true}

Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.37%

精彩评论

Cadrenal Therapeutics, Inc.盘中异动股价大涨5.37%